M

Moderna

Develops mRNA-based medicines for health

Infectious Disease Epidemiology Intern

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Internship · Summer 2027Cambridge, MA, USA

About the Job

Requirements

  • Candidates must be currently enrolled in a PhD or ScD program in Epidemiology or a closely related discipline.
  • Candidates must have a strong background in epidemiology and biostatistics.
  • Candidates must be available for the full internship duration, June 7, 2027 through August 20, 2027.
  • Candidates must already hold U.S. work authorization and be able to maintain that status without future sponsorship; only U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible due to export-control requirements.

Responsibilities

  • Gain exposure to epidemiology in vaccine development by supporting clinical trial conduct and post-marketing observational research.
  • Lead and execute epidemiologic analyses on infectious disease burden and related health outcomes, including study design, data analysis, and interpretation of results.
  • Communicate findings through data visualization, reports, and presentations to cross-functional teams and leadership.
  • Engage with cross-functional teams, including Clinical Development, Medical Affairs, Health Economics & Outcomes Research, and Real-World Evidence Analytics.
  • Contribute to regular cross-functional discussions on evidence-generation strategies for infectious disease programs, shaping research priorities and decision-making.

Desired Qualifications

  • Experience with SAS, R, STATA, or similar tools is a plus.
  • Interest in vaccine development, pharmacoepidemiologic methods, pharmacovigilance, and data-driven decision-making.
  • Ability to meet deadlines, adapt under pressure, and take a proactive approach to problem-solving.
  • Ability to work independently while contributing effectively within a team environment.
  • Strong written and verbal communication skills.
  • High attention to detail and commitment to quality and compliance.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs